You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

regorafenib

Showing 1 - 25 of 138
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Trifluridine/Tipiracil)

Recruiting
  • Metastatic Colorectal Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 24, 2023

TAS-102 in Combination With Regorafenib or Fruquintinib for

Not yet recruiting
  • TAS 102
  • +3 more
  • (no location specified)
Aug 7, 2023

Microsatellite Stable Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Toripalimab, High/low-dose radiotherapy)

Recruiting
  • Microsatellite Stable Metastatic Colorectal Cancer
  • Regorafenib
  • +2 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 19, 2023

MSI-H Colorectal Cancer Trial in Pittsburgh (Regorafenib, Pembrolizumab)

Not yet recruiting
  • MSI-H Colorectal Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 17, 2023

Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma Trial in Padova (Regorafenib, Temozolomide)

Recruiting
  • Glioblastoma, IDH-wildtype
  • MGMT-Methylated Glioblastoma
  • Padova, Italy
    Istituto Oncologico Veneto IRCCS
Oct 18, 2023

Colorectal Cancer Liver Metastases, Regorafenib Trial in Guangdong (Regorafenib and DIBIRI, Regorafenib)

Recruiting
  • Colorectal Cancer Liver Metastases
  • Regorafenib
  • Regorafenib and DIBIRI
  • Regorafenib
  • Guangdong, Guangzhou, China
    Bo Zhang
Mar 20, 2023

Colorectal Cancer Trial (Regorafenib)

Not yet recruiting
  • Colorectal Cancer
  • Regorafenib
  • (no location specified)
Apr 17, 2023

Colorectal Cancer Trial (KN046, regorafenib)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Aug 2, 2023

Digestive System Cancers Trial in Beijing (KN046, Regorafenib, Apatinib)

Recruiting
  • Digestive System Cancers
  • Beijing, China
    Peking University Cancer Hospital
Oct 25, 2023

Gastrointestinal Stromal Tumors Trial in Houston (Regorafenib)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Regorafenib
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2023

Gastrointestinal Stromal Tumors Trial in Miami (Sunitinib, Regorafenib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Miami, Florida
    University of Miami
Jan 3, 2023

Colorectal Liver Metastases Trial in Beijing (Tislelizumab, Regorafenib, HAIC)

Recruiting
  • Colorectal Liver Metastases
  • Beijing, Beijing, China
  • +1 more
May 25, 2023

Hepatocellular Carcinoma, Transcatheter Arterial ChEmoembolization, Regorafenib Trial in Guangzhou (TACE, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • TACE
  • Regorafenib
  • Guangzhou, Guangdong, China
    FirstSunYetSen
Apr 12, 2023

Colorectal Cancer, Colon Cancer, Rectum Cancer Trial in Houston (Regorafenib, XmAb20717)

Not yet recruiting
  • Colorectal Cancer
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 31, 2023

Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Kaohsiung, Taiwan
  • +4 more
Mar 14, 2023

Colo-rectal Cancer, Metastatic Cancer Trial in Besançon, Dijon, Montbéliard (Regorafenib, Cyclophosphamide, Capecitabine)

Active, not recruiting
  • Colo-rectal Cancer
  • Metastatic Cancer
  • Regorafenib
  • +3 more
  • Besançon, France
  • +2 more
Jan 24, 2023

Hepatocellular Carcinoma Trial in Winston-Salem (TheraBionic, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma
  • TheraBionic
  • Regorafenib
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Oct 26, 2022

Metastatic Colorectal Cancer (mCRC) Trial in France (Regorafenib, Irinotecan)

Recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • Nice, Alpes-Maritimes, France
  • +10 more
Jan 16, 2023

Liver Metastases, Colorectal Cancer Metastatic Trial in Shanghai (Sintilimab, Regorafenib, US/CT-guided Percutaneous

Recruiting
  • Liver Metastases
  • Colorectal Cancer Metastatic
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 8, 2022

Advanced Biliary Systemic Tumours That Has Failed at Least One Prior Systemic Therapy Trial in Tianjin (Cadonilimab Injection,

Recruiting
  • Advanced Biliary Systemic Tumours That Has Failed at Least One Prior Systemic Therapy
  • Cadonilimab Injection
  • Regorafenib
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Dec 7, 2022

Colorectal Cancer Trial in Pisa (Regorafenib, Panitumumab)

Recruiting
  • Colorectal Cancer
  • Pisa, PI, Italy
    U.O. Oncologia 2 Universitaria
Aug 3, 2022

Advanced Hepatocellular Carcinoma That Has Failed at Least One Prior Systemic Therapy Trial in Tianjin (Cadonilimab Injection,

Recruiting
  • Advanced Hepatocellular Carcinoma That Has Failed at Least One Prior Systemic Therapy
  • Cadonilimab Injection
  • Regorafenib
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Dec 7, 2022

Hepatocellular Carcinoma Trial in Seongnam-si, Seoul (regorafenib)

Recruiting
  • Hepatocellular Carcinoma
  • regorafenib
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +1 more
Sep 24, 2022

Advanced Colorectal Adenocarcinoma, Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Colorectal Adenocarcinoma

Not yet recruiting
  • Advanced Colorectal Adenocarcinoma
  • +5 more
  • Balstilimab
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Osteosarcoma, Ewing Sarcoma of Bone Trial in Warsaw (Regorafenib)

Recruiting
  • Osteosarcoma
  • Ewing Sarcoma of Bone
  • Regorafenib
  • Warsaw, Mazovian, Poland
    Mother and Child Institute
Sep 7, 2022